PMC:7212965 / 1974-2329 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8","span":{"begin":171,"end":176},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"ties were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\nGI symptoms are associated with COVID-19 in \u003c10% of patients. In studies outside of China, es"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T7","span":{"begin":171,"end":176},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"ties were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\nGI symptoms are associated with COVID-19 in \u003c10% of patients. In studies outside of China, es"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":48,"end":56},"obj":"Disease"},{"id":"T11","span":{"begin":239,"end":247},"obj":"Disease"},{"id":"T12","span":{"begin":294,"end":302},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ties were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\nGI symptoms are associated with COVID-19 in \u003c10% of patients. In studies outside of China, es"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T19","span":{"begin":171,"end":176},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T20","span":{"begin":171,"end":176},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"ties were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\nGI symptoms are associated with COVID-19 in \u003c10% of patients. In studies outside of China, es"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T8","span":{"begin":107,"end":109},"obj":"Chemical"},{"id":"T9","span":{"begin":262,"end":264},"obj":"Chemical"}],"attributes":[{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"}],"text":"ties were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\nGI symptoms are associated with COVID-19 in \u003c10% of patients. In studies outside of China, es"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T14","span":{"begin":48,"end":56},"obj":"Phenotype"}],"attributes":[{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0002014"}],"text":"ties were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\nGI symptoms are associated with COVID-19 in \u003c10% of patients. In studies outside of China, es"}

{"project":"LitCovid-sentences","denotations":[{"id":"T16","span":{"begin":98,"end":140},"obj":"Sentence"},{"id":"T17","span":{"begin":141,"end":248},"obj":"Sentence"},{"id":"T18","span":{"begin":250,"end":261},"obj":"Sentence"},{"id":"T19","span":{"begin":262,"end":323},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ties were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\nGI symptoms are associated with COVID-19 in \u003c10% of patients. In studies outside of China, es"}

{"project":"LitCovid-PubTator","denotations":[{"id":"53","span":{"begin":107,"end":109},"obj":"Gene"},{"id":"66","span":{"begin":48,"end":56},"obj":"Disease"},{"id":"67","span":{"begin":239,"end":247},"obj":"Disease"},{"id":"74","span":{"begin":262,"end":264},"obj":"Gene"},{"id":"76","span":{"begin":314,"end":322},"obj":"Species"},{"id":"77","span":{"begin":294,"end":302},"obj":"Disease"}],"attributes":[{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"Gene:2770"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D003967"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:C000657245"},{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"Gene:2770"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"Tax:9606"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ties were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\nGI symptoms are associated with COVID-19 in \u003c10% of patients. In studies outside of China, es"}